Humana (NYSE:HUM) Sets New 52-Week Low at $298.61

Humana Inc. (NYSE:HUM - Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $298.61 and last traded at $304.85, with a volume of 221564 shares. The stock had previously closed at $302.09.

Analyst Ratings Changes

HUM has been the topic of a number of research analyst reports. Argus lowered Humana from a "buy" rating to a "hold" rating in a research note on Wednesday, March 13th. Mizuho decreased their target price on Humana from $550.00 to $400.00 and set a "buy" rating on the stock in a research note on Friday, January 26th. The Goldman Sachs Group decreased their target price on Humana from $450.00 to $385.00 and set a "buy" rating on the stock in a research note on Wednesday, April 3rd. UBS Group decreased their target price on Humana from $334.00 to $326.00 and set a "neutral" rating on the stock in a research note on Thursday, April 25th. Finally, Cantor Fitzgerald decreased their target price on Humana from $391.00 to $360.00 and set a "neutral" rating on the stock in a research note on Thursday, April 25th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $424.50.

Humana Price Performance

The company has a market capitalization of $37.86 billion, a PE ratio of 19.56, a PEG ratio of 1.76 and a beta of 0.45. The firm has a fifty day moving average of $325.94 and a two-hundred day moving average of $392.00. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion during the quarter, compared to analysts' expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana's quarterly revenue was up 10.7% compared to the same quarter last year. During the same period in the prior year, the business posted $9.38 EPS. Research analysts anticipate that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Friday, June 28th. Humana's dividend payout ratio (DPR) is currently 22.04%.

Insiders Place Their Bets

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the company's stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the acquisition, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.29% of the company's stock.

Institutional Investors Weigh In On Humana

Several institutional investors and hedge funds have recently bought and sold shares of HUM. Auxano Advisors LLC bought a new position in shares of Humana in the 4th quarter worth approximately $540,000. Mariner LLC raised its position in shares of Humana by 2.3% in the 3rd quarter. Mariner LLC now owns 14,119 shares of the insurance provider's stock worth $6,869,000 after acquiring an additional 312 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Humana by 27.5% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider's stock worth $13,595,000 after acquiring an additional 6,034 shares in the last quarter. Silverarc Capital Management LLC bought a new position in shares of Humana in the 3rd quarter worth approximately $4,865,000. Finally, Vest Financial LLC raised its position in shares of Humana by 43.3% in the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider's stock worth $12,815,000 after acquiring an additional 8,455 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.